Clinical Trial Update: Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes [NA]

View source ↗

Summary

A University of Virginia-led clinical trial is evaluating artificial pancreas technology to reduce glycemic variability and improve cardiovascular health in Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Virginia | Conditions: Type 1 Diabetes | NA | Status: RECRUITING